3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
23
INDUSTRY
3
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Colorectal Neoplasms
13
Neoplasms
11
Breast Neoplasms
11
Carcinoma, Hepatocellular
10
Prostatic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Stomach Neoplasms
5
Lung Neoplasms
5
Anastomotic Leak
5
Uterine Cervical Neoplasms
4
Rectal Neoplasms
4
Ovarian Neoplasms
4
Lymphoma, Follicular
4
Stomatitis
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
HIV Infections
3
Disease
3
Depression
3
Carcinoma, Renal Cell
3
Vulvar Neoplasms
2
Surgical Wound Infection
2
Sleep Initiation and Maintenance Disorders
2
Skin Neoplasms
2
Sarcoma
2
Recurrence
2
Postoperative Complications
2
Pilonidal Sinus
2
Peritoneal Neoplasms
2
Neuroendocrine Tumors
2
Interventions
fasudil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Cognitive Dysfunction
×
90 days
×
Clear all
NCT06362707
2026-05-04
FEAD
Helse Stavanger HF
Phase 2
Recruiting
200 enrolled